{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:10:10Z","timestamp":1746097810200,"version":"3.40.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T00:00:00Z","timestamp":1388707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s40261-013-0162-1","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T12:01:04Z","timestamp":1388664064000},"page":"183-188","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of the Influence of Cyclosporine and Tacrolimus on the Pharmacokinetics of Prednisolone in Adult Male Kidney Transplant Recipients"],"prefix":"10.1007","volume":"34","author":[{"given":"Troels K.","family":"Bergmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole M.","family":"Isbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine A.","family":"Barraclough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott B.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett C.","family":"McWhinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine E.","family":"Staatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,3]]},"reference":[{"issue":"2","key":"162_CR1","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1124\/jpet.102.041921","volume":"304","author":"Y Shitara","year":"2003","unstructured":"Shitara Y, Itoh T, Sato H, et al. Inhibition of transporter-mediated hepatic uptake as a mechanism for drug\u2013drug interaction between cerivastatin and cyclosporin A. J Pharmacol Exp Ther. 2003;304(2):610\u20136.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"162_CR2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/pds.1895","volume":"19","author":"K Hedenmalm","year":"2010","unstructured":"Hedenmalm K, Alvan G, Ohagen P, et al. Muscle toxicity with statins. Pharmacoepidemiol Drug Saf. 2010;19(3):223\u201331.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1 Pt 2","key":"162_CR3","first-page":"1825","volume":"19","author":"P Dorian","year":"1987","unstructured":"Dorian P, Cardella C, Strauss M, et al. Cyclosporine nephrotoxicity and cyclosporine\u2013digoxin interaction prior to heart transplantation. Transpl Proc. 1987;19(1 Pt 2):1825\u20137.","journal-title":"Transpl Proc"},{"issue":"4","key":"162_CR4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/j.1552-4604.1992.tb03845.x","volume":"32","author":"I Robieux","year":"1992","unstructured":"Robieux I, Dorian P, Klein J, et al. The effects of cardiac transplantation and cyclosporine therapy on digoxin pharmacokinetics. J Clin Pharmacol. 1992;32(4):338\u201343.","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"162_CR5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/0091270005284852","volume":"46","author":"AJ Bergman","year":"2006","unstructured":"Bergman AJ, Burke J, Larson P, et al. Interaction of single-dose ezetimibe and steady-state cyclosporine in renal transplant patients. J Clin Pharmacol. 2006;46(3):328\u201336.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"162_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1034\/j.1399-3062.2002.01004.x","volume":"4","author":"CA Sable","year":"2002","unstructured":"Sable CA, Nguyen BY, Chodakewitz JA, et al. Safety and tolerability of caspofungin acetate in the treatment of fungal infections. Transpl Infect Dis. 2002;4(1):25\u201330.","journal-title":"Transpl Infect Dis"},{"issue":"11","key":"162_CR7","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1177\/0091270010385934","volume":"51","author":"S Rebello","year":"2011","unstructured":"Rebello S, Compain S, Feng A, et al. Effect of cyclosporine on the pharmacokinetics of aliskiren in healthy subjects. J Clin Pharmacol. 2011;51(11):1549\u201360.","journal-title":"J Clin Pharmacol"},{"issue":"8374","key":"162_CR8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(84)91778-1","volume":"1","author":"L Ost","year":"1984","unstructured":"Ost L. Effects of cyclosporin on prednisolone metabolism. Lancet. 1984;1(8374):451.","journal-title":"Lancet"},{"issue":"1","key":"162_CR9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00007890-198501000-00021","volume":"39","author":"E Langhoff","year":"1985","unstructured":"Langhoff E, Madsen S, Flachs H, et al. Inhibition of prednisolone metabolism by cyclosporine in kidney-transplanted patients. Transplantation. 1985;39(1):107\u20139.","journal-title":"Transplantation"},{"key":"162_CR10","first-page":"963","volume":"21","author":"E Langhoff","year":"1985","unstructured":"Langhoff E, Madsen S, Olgaard K, et al. Clinical results and cyclosporine effect on prednisolone metabolism of cadaver kidney transplanted patients. Proc Eur Dial Transpl Assoc Eur Ren Assoc. 1985;21:963\u20138.","journal-title":"Proc Eur Dial Transpl Assoc Eur Ren Assoc"},{"issue":"4","key":"162_CR11","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/00007890-198704000-00007","volume":"43","author":"FJ Frey","year":"1987","unstructured":"Frey FJ, Schnetzer A, Horber FF, et al. Evidence that cyclosporine does not affect the metabolism of prednisolone after renal transplantation. Transplantation. 1987;43(4):494\u20138.","journal-title":"Transplantation"},{"issue":"4","key":"162_CR12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00007890-198710000-00015","volume":"44","author":"L Ost","year":"1987","unstructured":"Ost L. Impairment of prednisolone metabolism by cyclosporine treatment in renal graft recipients. Transplantation. 1987;44(4):533\u20135.","journal-title":"Transplantation"},{"issue":"3","key":"162_CR13","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/00007890-198803000-00032","volume":"45","author":"ML Rocci Jr","year":"1988","unstructured":"Rocci ML Jr, Tietze KJ, Lee J, et al. The effect of cyclosporine on the pharmacokinetics of prednisolone in renal transplant patients. Transplantation. 1988;45(3):656\u201360.","journal-title":"Transplantation"},{"issue":"4","key":"162_CR14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00007691-200408000-00011","volume":"26","author":"JM Potter","year":"2004","unstructured":"Potter JM, McWhinney BC, Sampson L, et al. Area-under-the-curve monitoring of prednisolone for dose optimization in a stable renal transplant population. Ther Drug Monit. 2004;26(4):408\u201314.","journal-title":"Ther Drug Monit"},{"issue":"28","key":"162_CR15","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1016\/j.jchromb.2010.08.044","volume":"878","author":"BC McWhinney","year":"2010","unstructured":"McWhinney BC, Briscoe SE, Ungerer JP, et al. Measurement of cortisol, cortisone, prednisolone, dexamethasone and 11-deoxycortisol with ultra high performance liquid chromatography\u2013tandem mass spectrometry: application for plasma, plasma ultrafiltrate, urine and saliva in a routine laboratory. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878(28):2863\u20139.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"162_CR16","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00228-011-1071-y","volume":"67","author":"KA Barraclough","year":"2011","unstructured":"Barraclough KA, Isbel NM, McWhinney BC, et al. Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients. Eur J Clin Pharmacol. 2011;67:1243\u201352.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"162_CR17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1210\/jcem-56-4-702","volume":"56","author":"SJ Boekenoogen","year":"1983","unstructured":"Boekenoogen SJ, Szefler SJ, Jusko WJ. Prednisolone disposition and protein binding in oral contraceptive users. J Clin Endocrinol Metab. 1983;56(4):702.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"162_CR18","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/00912700122012733","volume":"41","author":"MH Magee","year":"2001","unstructured":"Magee MH, Blum RA, Lates CD, et al. Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race. J Clin Pharmacol. 2001;41(11):1180\u201394.","journal-title":"J Clin Pharmacol"},{"issue":"11","key":"162_CR19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40262-012-0007-8","volume":"51","author":"TK Bergmann","year":"2012","unstructured":"Bergmann TK, Barraclough KA, Lee KJ, et al. Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation. Clin Pharmacokinet. 2012;51(11):711\u201341.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"162_CR20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/clpt.2011.130","volume":"90","author":"H Jonge de","year":"2011","unstructured":"de Jonge H, de Loor H, Verbeke K, et al. In vivo CYP3A activity is significantly lower in cyclosporine-treated as compared with tacrolimus-treated renal allograft recipients. Clin Pharmacol Ther. 2011;90(3):414\u201322.","journal-title":"Clin Pharmacol Ther"},{"issue":"1\u20132","key":"162_CR21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejps.2005.12.006","volume":"28","author":"H Saitoh","year":"2006","unstructured":"Saitoh H, Saikachi Y, Kobayashi M, et al. Limited interaction between tacrolimus and P-glycoprotein in the rat small intestine. Eur J Pharm Sci. 2006;28(1\u20132):34\u201342.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"162_CR22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00007691-198004000-00011","volume":"2","author":"WJ Jusko","year":"1980","unstructured":"Jusko WJ, Rose JQ. Monitoring prednisone and prednisolone. Ther Drug Monit. 1980;2(2):169\u201376.","journal-title":"Ther Drug Monit"},{"issue":"1","key":"162_CR23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jps.20768","volume":"96","author":"M Vogt","year":"2007","unstructured":"Vogt M, Derendorf H, Kramer J, et al. Biowaiver monographs for immediate release solid oral dosage forms: prednisolone. J Pharm Sci. 2007;96(1):27\u201337.","journal-title":"J Pharm Sci"},{"issue":"2","key":"162_CR24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0022-3565(24)37815-2","volume":"287","author":"R Kawai","year":"1998","unstructured":"Kawai R, Mathew D, Tanaka C, et al. Physiologically based pharmacokinetics of cyclosporine A: extension to tissue distribution kinetics in rats and scale-up to human. J Pharmacol Exp Ther. 1998;287(2):457\u201368.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"162_CR25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/jat\/15.3.110","volume":"15","author":"GL Lensmeyer","year":"1991","unstructured":"Lensmeyer GL, Wiebe DA, Carlson IH, et al. Concentrations of cyclosporin A and its metabolites in human tissues postmortem. J Anal Toxicol. 1991;15(3):110\u20135.","journal-title":"J Anal Toxicol"},{"issue":"1","key":"162_CR26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0163-7258(89)90025-9","volume":"42","author":"MA McMillan","year":"1989","unstructured":"McMillan MA. Clinical pharmacokinetics of cyclosporin. Pharmacol Ther. 1989;42(1):135\u201356.","journal-title":"Pharmacol Ther"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-013-0162-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-013-0162-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-013-0162-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T10:32:28Z","timestamp":1746095548000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-013-0162-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["162"],"URL":"https:\/\/doi.org\/10.1007\/s40261-013-0162-1","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"type":"print","value":"1173-2563"},{"type":"electronic","value":"1179-1918"}],"subject":[],"published":{"date-parts":[[2014,1,3]]}}}